ENGN
enGene Therapeutics Inc. - Common Stock (ENGN)
$89
About enGene Therapeutics Inc. - Common Stock (ENGN)
enGene Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs. The company was founded by Anthony T. Cheung on April 24, 2023 and is headquartered in Saint-Laurent, Canada.
Details
Daily high
$1.90
Daily low
$1.84
Price at open
$1.87
52 Week High
$12.25
52 Week Low
$1.40
Market cap
125.3M
Dividend yield
-
Volume
618,746
Avg. volume
709,154
P/E ratio
-.90
enGene Therapeutics Inc. - Common Stock News
Details
Daily high
$1.90
Daily low
$1.84
Price at open
$1.87
52 Week High
$12.25
52 Week Low
$1.40
Market cap
125.3M
Dividend yield
-
Volume
618,746
Avg. volume
709,154
P/E ratio
-.90